Septilisin Duo comprimidos

Array
(
    [ID] => 1370
    [post_author] => 16
    [post_date] => 2012-06-26 18:27:32
    [post_date_gmt] => 2012-06-26 18:27:32
    [post_content] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:
Cefalexina (como Cefalexina Monohidrato) 1000 mg
Acción Terapéutica:
Antibiótico de uso sistémico. Cefalosporina de primera generación.
Indicaciones:
Septilisin Dúo está indicado en niños y adolescentes mayores de 12 años y en adultos en el tratamiento de las siguientes infecciones debidas a microorganismos sensibles:
-Faringoamigdalitis causada por Streptococcus del grupo A y otitis media aguda.
-Exacerbación de la bronquitis crónica y neumonía leve o moderada adquirida en la comunidad.
-Impétigo, celulitis, erisipela.
-Absceso cutáneo complicado, foliculitis extensa, forúnculo abscedado.
-Cistitis y prostatitis aguda.
Presentaciones:
Envases conteniendo 14 comprimidos recubiertos.
    [post_title] => Septilisin Duo comprimidos
    [post_excerpt] => Antibiótico bactericida por vía oral. Cefalosporina de primera generación.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => septilisin-duo
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2024-12-02 10:05:32
    [post_modified_gmt] => 2024-12-02 13:05:32
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1370
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19800
                    [post_author] => 16
                    [post_date] => 2024-12-02 09:56:31
                    [post_date_gmt] => 2024-12-02 12:56:31
                    [post_content] => 
                    [post_title] => SEPTILISIN DUO Información paciente Disp. 8393-20
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => septilisin-duo-informacion-paciente-disp-8393-20
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 09:56:31
                    [post_modified_gmt] => 2024-12-02 12:56:31
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/12/SEPTILISIN-DUO-Informacion-paciente-Disp.-8393-20.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19799
                    [post_author] => 16
                    [post_date] => 2024-12-02 09:56:30
                    [post_date_gmt] => 2024-12-02 12:56:30
                    [post_content] => 
                    [post_title] => SEPTILISIN DUO Prospecto Disp. 8393-20
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => septilisin-duo-prospecto-disp-8393-20
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 09:56:30
                    [post_modified_gmt] => 2024-12-02 12:56:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/12/SEPTILISIN-DUO-Prospecto-Disp.-8393-20.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19802
                    [post_author] => 16
                    [post_date] => 2024-12-02 10:04:10
                    [post_date_gmt] => 2024-12-02 13:04:10
                    [post_content] => 
                    [post_title] => img_septilisin_duo
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => img_septilisin_duo
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 10:04:10
                    [post_modified_gmt] => 2024-12-02 13:04:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/12/img_septilisin_duo.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Septilisin
        )

    [principio_activo] => Array
        (
            [0] => Cefalexina
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:

Cefalexina (como Cefalexina Monohidrato) 1000 mg
Acción Terapéutica:
Antibiótico de uso sistémico. Cefalosporina de primera generación.
Indicaciones:
Septilisin Dúo está indicado en niños y adolescentes mayores de 12 años y en adultos en el tratamiento de las siguientes infecciones debidas a microorganismos sensibles:

-Faringoamigdalitis causada por Streptococcus del grupo A y otitis media aguda.

-Exacerbación de la bronquitis crónica y neumonía leve o moderada adquirida en la comunidad.

-Impétigo, celulitis, erisipela.

-Absceso cutáneo complicado, foliculitis extensa, forúnculo abscedado.

-Cistitis y prostatitis aguda.
Presentaciones:
Envases conteniendo 14 comprimidos recubiertos.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/SEPTILISIN-DUO-Prospecto-Disp.-8393-20.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:196232;}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2024/12/SEPTILISIN-DUO-Informacion-paciente-Disp.-8393-20.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:155218;}
        )

)

anexo_congre_single